LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 88 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,976,230 | -52.8% | 6,400,211 | -0.9% | 0.00% | – |
| Q2 2023 | $14,786,421 | +14.8% | 6,456,952 | +21.8% | 0.00% | – |
| Q1 2023 | $12,877,493 | +28.3% | 5,299,380 | +0.8% | 0.00% | – |
| Q4 2022 | $10,039,625 | -20.4% | 5,256,348 | +0.0% | 0.00% | – |
| Q3 2022 | $12,614,000 | +72.9% | 5,256,288 | +34.0% | 0.00% | – |
| Q2 2022 | $7,295,000 | -16.0% | 3,921,970 | -5.6% | 0.00% | – |
| Q1 2022 | $8,686,000 | -46.9% | 4,156,236 | +0.1% | 0.00% | – |
| Q4 2021 | $16,358,000 | -14.7% | 4,151,752 | +4.2% | 0.00% | – |
| Q3 2021 | $19,168,000 | +5.2% | 3,985,180 | +0.4% | 0.00% | – |
| Q2 2021 | $18,222,000 | -21.6% | 3,969,989 | +0.3% | 0.00% | -100.0% |
| Q1 2021 | $23,238,000 | +92.8% | 3,958,847 | +12.3% | 0.00% | – |
| Q4 2020 | $12,053,000 | +194.3% | 3,524,074 | +23.8% | 0.00% | – |
| Q3 2020 | $4,096,000 | -17.2% | 2,845,641 | +14.7% | 0.00% | – |
| Q2 2020 | $4,949,000 | -20.7% | 2,480,786 | -22.5% | 0.00% | – |
| Q1 2020 | $6,241,000 | -49.5% | 3,200,674 | +7.5% | 0.00% | – |
| Q4 2019 | $12,351,000 | +34.0% | 2,976,003 | -2.8% | 0.00% | – |
| Q3 2019 | $9,217,000 | -65.4% | 3,061,989 | -27.8% | 0.00% | -100.0% |
| Q2 2019 | $26,670,000 | +22.3% | 4,240,111 | +8.1% | 0.00% | 0.0% |
| Q1 2019 | $21,800,000 | +10.0% | 3,920,729 | +31.3% | 0.00% | 0.0% |
| Q4 2018 | $19,821,000 | -51.6% | 2,985,162 | -22.2% | 0.00% | -50.0% |
| Q3 2018 | $40,917,000 | -9.4% | 3,834,766 | +1.9% | 0.00% | 0.0% |
| Q2 2018 | $45,145,000 | +40.7% | 3,762,126 | +0.5% | 0.00% | +100.0% |
| Q1 2018 | $32,078,000 | -10.8% | 3,742,884 | +2.8% | 0.00% | -50.0% |
| Q4 2017 | $35,962,000 | -17.7% | 3,639,925 | +2.3% | 0.00% | 0.0% |
| Q3 2017 | $43,712,000 | -28.3% | 3,556,761 | -4.1% | 0.00% | -33.3% |
| Q2 2017 | $61,001,000 | +2.1% | 3,708,247 | -11.0% | 0.00% | 0.0% |
| Q1 2017 | $59,773,000 | +20.6% | 4,168,301 | +16.3% | 0.00% | 0.0% |
| Q4 2016 | $49,554,000 | -19.7% | 3,583,079 | +5.0% | 0.00% | -25.0% |
| Q3 2016 | $61,685,000 | +27.7% | 3,413,649 | +1.4% | 0.00% | +33.3% |
| Q2 2016 | $48,314,000 | +32.0% | 3,366,813 | +9.9% | 0.00% | +50.0% |
| Q1 2016 | $36,613,000 | -7.5% | 3,063,884 | +3.0% | 0.00% | -33.3% |
| Q4 2015 | $39,600,000 | +26.7% | 2,975,216 | +2.2% | 0.00% | +200.0% |
| Q3 2015 | $31,255,000 | +36.0% | 2,910,082 | +1.9% | 0.00% | -50.0% |
| Q2 2015 | $22,988,000 | – | 2,855,629 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |